An electrostatic force-independent dephosphorylation-driven chemiluminescent biosensor for sensitive and rapid detection of poly(ADP-ribose) polymerase-1 in human breast tissues
Ming-hao Liu,Feng-zheng Li,Wen-jing Liu,Juan Hu,Meng Liu,Chun-Yang Zhang
DOI: https://doi.org/10.1016/j.cej.2023.141776
IF: 15.1
2023-02-13
Chemical Engineering Journal
Abstract:Poly (ADP-ribose) polymerase-1 (PARP-1) is a multi-domain nuclear enzyme that mediates gene transcription and DNA repair. Accurate detection of PARP-1 is essential to clinical diagnostic. However, conventional PARP-1 assays rely on electrostatic force with the involvement of lengthy and complex construction processes and false positive. Herein, we construct an ultrasensitive chemiluminescent biosensor for rapid detection of PARP-1 in human breast tissues by integrating PARP-1-directed hyperbranched poly(ADP-ribose) (PAR) formation with alkaline phosphatase (ALP)-3-(2′-spiroadamantyl)-4-methoxy-4- (3′'-phosphoryloxyphenyl)-1,2-dioxetane (AMPDD)-mediated chemiluminescence system. Upon activation by dsDNA, PARP-1 cleaves nicotinamide adenine dinucleotide (NAD + ), initiating the repeated polymerization of biotinylated ADP-ribose to form the dsDNA- PAR-biotin complex. The subsequent assembly of dsDNA-PAR-biotin complexes onto AuNPs through Au-S covalent bond results in the construction of the AuNPs-dsDNA-biotin nanostructure. AuNPs-dsDNA-biotin nanostructure subsequently captures SA-ALP to form the AuNPs-dsDNA-ALP nanostructure. After centrifugation and separation, the AuNPs-dsDNA-ALP nanostructure initiates the dephosphorylation of AMPPD to produce a high chemiluminescent signal. In this assay, only PARP-1 activated by dsDNA can cleave NAD + , efficiently eliminating background signal. The introduction of frozen method greatly shortens the assay time. Benefiting from high precision of the PARP-1-catalyzed NAD + cleavage, high efficiency of biotinylated ADP-ribose polymerization reaction, and high signal-to-noise ratio of ALP-AMPPD chemiluminescence system, this biosensor can rapidly and sensitively detect PARP-1 with a detection limit of 2.94 × 10 −7 U/μL, accurately screen PARP-1 inhibitors, and quantify PARP-1 at single-cell level. Most importantly, it can differentiate PARP-1 expression between breast cancer patient tissues and healthy person tissues, with promising applications in clinical diagnosis and biomedical research.
engineering, chemical, environmental